Related references
Note: Only part of the references are listed.New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen et al.
NATURE MEDICINE (2014)
CD25 and CD69 induction by α4β1 outside-in signalling requires TCR early signalling complex proteins
Ann-Marie Cimo et al.
BIOCHEMICAL JOURNAL (2013)
Targeting HIV latency: pharmacologic strategies toward eradication
Sifei Xing et al.
DRUG DISCOVERY TODAY (2013)
CTIP2 is a negative regulator of P-TEFb
Thomas Cherrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
14-Step Synthesis of (+)-Ingenol from (+)-3-Carene
Lars Jorgensen et al.
SCIENCE (2013)
An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+T Cells from Aviremic Patients
Celsa A. Spina et al.
PLOS PATHOGENS (2013)
Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
Mark Lebwohl et al.
JAMA DERMATOLOGY (2013)
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat et al.
AIDS (2012)
In Vitro Phenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors
Benoit Visseaux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The role of cytokines in the establishment, persistence and eradication of the HIV reservoir
Claire Vandergeeten et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Evelyn Eisele et al.
IMMUNITY (2012)
Latent HIV-1 Infection Occurs in Multiple Subsets of Hematopoietic Progenitor Cells and Is Reversed by NF-κB Activation
Lucy A. McNamara et al.
JOURNAL OF VIROLOGY (2012)
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs
Lisa N. McKernan et al.
ADVANCES IN VIROLOGY (2012)
The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
Faisal R. Ali et al.
DERMATOLOGY AND THERAPY (2012)
De novo assembly of Euphorbia fischeriana root transcriptome identifies prostratin pathway related genes
Roberto A. Barrero et al.
BMC GENOMICS (2011)
Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Gonzalo Sanchez-Duffhues et al.
CURRENT DRUG TARGETS (2011)
Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
Julia Friedman et al.
JOURNAL OF VIROLOGY (2011)
Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1
Li Huang et al.
PLOS ONE (2011)
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
Paul A. Wender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HIV Latency
Robert F. Siliciano et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity
Thierry Huet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Cell line-dependent variability in HIV activation employing DNMT inhibitors
Guerau Fernandez et al.
VIROLOGY JOURNAL (2010)
The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
Elisabeth Ersvaer et al.
TOXINS (2010)
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
Sophie Reuse et al.
PLOS ONE (2009)
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
Laurence Colin et al.
RETROVIROLOGY (2009)
Shock and kill effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
Andrea Savarino et al.
RETROVIROLOGY (2009)
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Steven E. Kauder et al.
PLOS PATHOGENS (2009)
Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation
Nieves Marquez et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
Takeshi Shimamura et al.
CANCER RESEARCH (2008)
Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
Stephen A. Migueles et al.
IMMUNITY (2008)
Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV
Paul A. Wender et al.
SCIENCE (2008)
HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription
Xavier Contreras et al.
PLOS PATHOGENS (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
Phorbol esters: Structure, biological activity, and toxicity in animals
Gunjan Goel et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2007)
HIV type 1 inhibition by protein kinase C modulatory compounds
David Warrilow et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Chemistry and biological activity of secondary metabolites in Euphorbia from Iran
Amir Reza Jassbi
PHYTOCHEMISTRY (2006)
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents
J Kulkosky et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Can HIV be cured? Mechanisms of HIV persistence and strategies to combat it
DH Hamer
CURRENT HIV RESEARCH (2004)
Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription
MS Zhou et al.
JOURNAL OF VIROLOGY (2004)
Mechanisms for macrophage-mediated HIV-1 induction
K Devadas et al.
JOURNAL OF IMMUNOLOGY (2004)
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2)
A Gupta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue
A Biancotto et al.
JOURNAL OF VIROLOGY (2004)
Involvement of PKC βII in anti-proliferating action of a new antitumor compound gnidimacrin
M Yoshida et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate
S Bocklandt et al.
ANTIVIRAL RESEARCH (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
O Rohr et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype
DD Scripture-Adams et al.
JOURNAL OF VIROLOGY (2002)
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
J Kulkosky et al.
BLOOD (2001)
Ingenol esters induce apoptosis in Jurkat cells through an AP-1 and NF-κB independent pathway
M Blanco-Molina et al.
CHEMISTRY & BIOLOGY (2001)
NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II
M Barboric et al.
MOLECULAR CELL (2001)
Partners in transcription:: NFAT and AP-1
F Macián et al.
ONCOGENE (2001)
Share Paper
